Online National Drugs Licensing System (ONDLS) Portal

The Online National Drugs Licensing System (ONDLS) is a significant digital initiative aimed at streamlining the licensing process for drugs and pharmaceutical products in India. Recently, it's been reported that although 18 state drug control authorities have adopted the platform, no state has yet fully complied with the Corrective and Preventive Action (CAPA) guidelines for the portal, according to a source in the Union Health Ministry.

What is the ONDLS Portal?

The ONDLS is a single-window digital platform designed for the processing of various drug-related licenses across India. It provides a centralized, transparent, and efficient system for handling applications related to the issuance of licenses and certificates for drug manufacturing, sales, and related activities.

Key Features of ONDLS:

• Uniform Licensing Process:
  The system ensures a uniform approach to licensing across the country, which means that drug regulatory requirements and the process of obtaining licenses are standardized across all states and Union Territories.

• Types of Licenses Processed:
  It handles the issuance of a variety of licenses and certificates, including:

  • Manufacturing and sales licenses

  • Blood Bank licenses

  • Certificates such as COPP (Certificate of Pharmaceutical Product), GMP (Good Manufacturing Practices), WHO-GMP, and Market Standing Certificate

  • Post-approval changes to licenses

• Integration with Regulatory Authorities:
  The ONDLS platform is developed by the Centre for Development of Advanced Computing (CDAC) in collaboration with the Central Drugs Standard Control Organisation (CDSCO), the Directorate General of Health Services, and State/UT Drugs Regulatory Authorities.

Benefits of the ONDLS Portal:

1. Transparency and Accountability:
   The digital platform ensures that the drug licensing process is transparent, trackable, and accountable, thus reducing corruption and administrative delays.

2. Ease of Access:
   The portal is designed to make the licensing process accessible online, eliminating the need for physical visits to drug control offices, which simplifies the procedure for applicants.

3. Efficiency:
   ONDLS enhances the efficiency of licensing, as it streamlines the entire process, from application submission to approval, and reduces human error and processing time.

4. Document Standardization:
   The system aims to standardize the types of documents required for different types of applications across the country, ensuring uniformity in the licensing process.

5. Support for Drug-Related Regulations:
   It helps to ensure that drug-related establishments such as manufacturers, distributors, and pharmacies comply with national standards for safety and efficacy.

Challenges Faced:

• Non-Compliance with CAPA Guidelines:
  A key challenge is that although many states have adopted the ONDLS platform, none have fully complied with the Corrective and Preventive Action (CAPA) guidelines. This implies that certain corrective measures to optimize the system or prevent errors are still pending in most regions.

• Need for Full Implementation:
  For the system to be effective nationwide, full compliance with the CAPA guidelines and broader adoption across all states and UTs is crucial.

Conclusion:

The ONDLS portal is a pioneering initiative aimed at transforming the drug licensing system in India, making it more transparent, efficient, and standardized. However, its success hinges on full compliance with guidelines across all states and Union Territories, and the implementation of corrective actions to address any discrepancies. Once these challenges are addressed, the ONDLS has the potential to significantly improve the regulatory landscape for pharmaceuticals in India